Author

J. Tuju

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1

Frequent Co-Authors

F. Osier· 2 shared K. Mwai· 2 shared L. Nyamako· 2 shared R. Kimathi· 2 shared A. B. Deme· 1 shared A. K. Bei· 1 shared A. M. Mbaye· 1 shared B. Dieye· 1 shared

Activity by Year

2018-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

F. Osier

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Breadth of Fc-mediated effector function delineates grades of clinical immunity following human malaria challenge

I. N. Nkumama, D. Odera, F. Musasia, K. Mwai, L. Nyamako, L. Murungi, J. Tuju, K. Furle, M. Rosenkranz, R. Kimathi, P. Njuguna, M. Hamaluba, M. C. Kapulu, R. Frank, CHMI-SIKA Study Team, F. Osier

The paper compares seven antibody assays to identify which best correlate with immunity to malaria, finding that Fc-mediated effector function breadth is a strong indicator of protection.

bioRxiv · Oct 11, 2022 · PreprintImmunology

High-throughput profiling of natural acquired humoral immune response to a large panel of known and novel full length ectodomain P. falciparum merozoite vaccine candidates under reduced malaria transmission.

D. N. Ndegwa, J. Tuju, E. Chepsat, R. Kimathi, K. Mwai, L. Nyamako, B. Dieye, M. Mosobo, A. B. Deme, I. M. Ndiaye, M. Sy, M. A. Diallo, Y. Diedhiou, A. M. Mbaye, D. Wirth, , A. K. Bei

The paper profiles natural humoral immunity to P. falciparum vaccine candidates in a low transmission setting, identifying antigens that induce high, moderate, or low antibody responses.

bioRxiv · Feb 15, 2022 · PreprintImmunology

Comprehensive profiling of antibodies against multiple infectious diseases in serum and the airway mucosa using synthetic peptide-based linear epitope microarrays

C. J. Sande, T. Chege, M. N. Mutunga, E. Gicheru, D. J. Nokes, C. A. Green, J. Tuju

The paper develops a synthetic peptide microarray to profile antibodies against 41 infectious diseases in serum and mucosal samples from infants, revealing antigen-specific antibody patterns and decay kinetics.

bioRxiv · Nov 5, 2018 · PreprintImmunology